CD33 and Alzheimer disease: Consistent with the effect of the interaction between APOE ε4 and CRP on CSF AD biomarkers [43], this study also demonstrated that the combination of elevated CRP and AD-associated genotype in SPI1 or CD33 was associated with increased CSF t-Tau and p-Tau levels.